Validate Turkish involuntary movements scale
- Trial ID
- NCT07023224
- Official Title
- Adaptation Of The Parkinson's Disease Dyskinesia Questionnaire Into Turkish And Its Validity And Reliability In Parkinson's Patient
- Goal
- Validate Turkish involuntary movements scale
- Status
- RECRUITING
- Sponsor
- Izmir Bakircay University
- Study Type
- OBSERVATIONAL
- Enrollment
- 130 participants
- Conditions
- Idiopathic Parkinson Disease, Dyskinesias, Quality of Life
- Interventions
- Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
Plain-Language Summary
They want to adapt the Parkinson's Disease Dyskinesia Scale (PDYS-26) into Turkish and make sure the translation accurately measures dyskinesias and how those involuntary movements affect quality of life. The team will have people with Parkinson's complete the Turkish PDYS-26 and test its validity and reliability, checking whether responses consistently reflect the frequency, severity, and daily-life impact of dyskinesia so clinicians and researchers can trust the tool. Adults with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who have at least mild dyskinesia on the UPDRS, can give consent, and score 24 or higher on the Mini Mental State Exam are eligible, while those with atypical parkinsonism or major health problems that would affect assessments are excluded.
Locations
- Bakirçay University Çiğli Regional Education Hospital, Izmir, İ̇zmi̇r, Turkey (Türkiye)
- Izmir Bakırçay Univercity, Izmir, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26). They want to adapt the Parkinson's Disease Dyskinesia Scale (PDYS-26) into Turkish and make sure the translation accurately measures dyskinesias and how those involuntary movements affect quality of life. The team will have people with Parkinson's complete the Turkish PDYS-26 and test its validity and reliability, checking whether responses consistently reflect the frequency, severity, and daily-life impact of dyskinesia so clinicians and researchers can trust the tool. Adults with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who have at least mild dyskinesia on the UPDRS, can give consent, and score 24 or higher on the Mini Mental State Exam are eligible, while those with atypical parkinsonism or major health problems that would affect assessments are excluded.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.